Corcept Therapeutics (CORT)
undefined
undefined%
At close: undefined
55.40
0.00%
After-hours Dec 13, 2024, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income 106.14M 101.42M 112.51M 106.01M 94.18M 75.41M 129.12M 8.14M -6.41M -31.38M -46.01M -38.05M -32.35M -25.97M -20.17M -20.06M -11.57M -24.87M -20.09M -15.53M -9.81M
Depreciation & Amortization 2.36M 2.97M 3.07M 2.24M 2.17M 236.00K 106.00K 87.00K 155.00K 141.00K 74.00K 27.00K 3.00K 6.00K 10.00K 12.00K 13.00K 14.00K 704.00K 1.61M 22.55K
Stock-Based Compensation 48.94M 42.44M 42.93M 33.54M 29.31M 23.75M 13.36M 7.06M 6.01M 5.20M 5.20M 5.31M 3.44M 2.12M 1.80M 1.62M 1.06M - 697.00K 1.61B -
Other Working Capital 11.24M 3.49M 1.52M 1.27M -568.00K 14.38M -4.30M 4.51M 3.13M -2.89M 2.42M 21.00K -1.28M 2.01M 407.00K -1.41M -663.00K 68.00K 2.09M -227.58M -477.31K
Other Non-Cash Items -9.13M 1.38M 5.09M 1.45M -1.74M -1.72M 763.00K 1.95M 2.87M 3.71M 4.45M 1.70M - - 16.00K 1.28M 1.06M 1.55M 70.00K 78.42K 264.24K
Deferred Income Tax -29.49M -33.91M 4.35M 14.09M 16.88M 14.07M -76.70M - - - - - - - - - -1.06M - -697.00K -1.61B -
Change in Working Capital 8.22M 6.02M -57.00K -5.36M -4.69M 3.93M -5.71M 1.16M 500.00K -5.04M -762.00K -5.01M 1.52M 1.56M 373.00K -1.22M -464.00K 68.00K 2.08M 128.23K -477.31K
Operating Cash Flow 127.04M 120.32M 167.89M 151.97M 136.12M 115.67M 60.94M 18.39M 3.13M -27.38M -37.06M -36.02M -27.40M -22.29M -17.97M -18.36M -10.96M -23.24M -17.23M -13.72M -10.00M
Capital Expenditures -139.00K -413.00K -469.00K -1.24M -1.09M -298.00K -419.00K -194.00K -17.00K -174.00K -127.00K -151.00K -25.00K - -7.00K -7.00K - -1.31M -25.86M -103.90M -
Acquisitions - 113.91M -136.59M 118.03M 116.74M - - - - - - - - - - - - - 25.92M - -
Purchase of Investments -328.75M -355.07M -312.81M -420.11M -299.04M -233.12M -73.04M - - - - - - - -3.59M -3.59M -6.38M - -25.86M -103.90B -11.67M
Sales Maturities Of Investments 419.79M 241.15M 449.40M 302.09M 182.29M 142.66M - - - - - - - - 3.59M 5.93M 1.00M 26.68M 40.97M 64.38M 13.30M
Other Investing Acitivies - -113.91M 136.59M -118.03M -116.74M -90.47M -73.04M - - - - - - - 3.60M - - - -59.00K 103.90B -
Investing Cash Flow 90.91M -114.33M 136.13M -119.26M -117.83M -90.77M -73.46M -194.00K -17.00K -174.00K -127.00K -151.00K -25.00K - 3.59M 2.33M -5.38M 25.36M 15.11M -39.51M 1.64M
Debt Repayment - - - - - - -15.13M -14.78M -9.21M -4.86M - 29.86M - -6.00K -10.00K -13.00K -13.00K -12.00K -5.00K - -
Common Stock Repurchased -145.43M -21.66M -295.99M -9.95M -30.98M -23.66M - - - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - - -
Other Financial Acitivies -3.29M 4.38M -6.61M 22.16M 2.33M 9.32M 7.18M 7.68M 22.28M 1.78M -1.02M 59.71M - - - - 18.00K 43.00K 16.00K 62.39K 37.30K
Financial Cash Flow -148.72M -17.28M -302.59M 12.21M -28.64M -14.34M -7.95M -7.10M 13.07M -3.08M -970.00K 89.57M 42.48M 23.00M 23.52M 19.32M 18.87M 2.97M 12.00K 49.09M 37.57K
Net Cash Flow 69.22M -11.29M 1.43M 44.92M -10.36M 10.56M -20.47M 11.10M 16.19M -30.63M -38.16M 53.40M 15.06M 711.00K 9.15M 3.28M 2.53M 5.09M -2.11M -4.14M -8.33M
Free Cash Flow 126.90M 119.91M 167.42M 150.73M 135.03M 115.37M 60.52M 18.20M 3.11M -27.55M -37.19M -36.17M -27.43M -22.29M -17.98M -18.37M -10.96M -24.55M -43.10M -117.62M -10.00M